∞-Lipoic acid (ALA) is a naturally occuring cofactor that serves as an acyl carrier in oxidative decarboxylation of α-keto acids in carbohydrate metabolism. Current findings suggest that ∞-lipoic acid and its reduced form, dihydrolipoic acid (DHLA) may act as antioxidants and are able to quench free radicals in vitro and in vivo. However, the mechanism underlying the process is still unknown. In this study, atherosclerotic lesions were induced in six groups of adult male NZW rabbits labelled as group K, A, B, C, D, E (n=6) by giving 100g/head/day of 2% cholesterol-rich diet for ten weeks. While group K acted as a control, the rest were supplemented with ALA orally (1.4, 2.8, 4.2, 8.0 and 10mg/kg, respectively). In week ten, venous blood samples drawn from ear lobes were analysed for complete lipid profile and peroxidation index. The results showed a significant reduction of total cholesterol (TC) and low density lipoprotein-cholesterol (LDL-C) levels in most of the treated groups as compared to the control whereas apo-A levels showed a significant increase in group C and D. However, microsomal lipid peroxidation index, malondialdehyde (MDA) was found to be not significantly different. These findings suggest that ∞-lipoic acid may act as a lipid lowering agent in dose dependent manner in premature stage of atherosclerosis but was unable to inhibit lipid peroxidation processes in matured stage of atherosclerosis in rabbits fed a high cholesterol diet.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433964PMC

Publication Analysis

Top Keywords

∞-lipoic acid
16
findings ∞-lipoic
8
lipid peroxidation
8
stage atherosclerosis
8
lipid
5
∞-lipoic
4
acid blood
4
blood lipid
4
lipid levels
4
levels malondialdehyde
4

Similar Publications

A conifer metabolite corrects episodic ataxia type 1 by voltage sensor-mediated ligand activation of Kv1.1.

Proc Natl Acad Sci U S A

January 2025

Bioelectricity Laboratory, Department of Physiology and Biophysics, School of Medicine, University of California, Irvine, CA 92697.

Loss-of-function sequence variants in , which encodes the voltage-gated potassium channel Kv1.1, cause Episodic Ataxia Type 1 (EA1) and epilepsy. Due to a paucity of drugs that directly rescue mutant Kv1.

View Article and Find Full Text PDF

Norepinephrine in vertebrates and its invertebrate analog, octopamine, regulate the activity of neural circuits. We find that, when hungry, larvae switch activity in type II octopaminergic motor neurons (MNs) to high-frequency bursts, which coincide with locomotion-driving bursts in type I glutamatergic MNs that converge on the same muscles. Optical quantal analysis across hundreds of synapses simultaneously reveals that octopamine potentiates glutamate release by tonic type Ib MNs, but not phasic type Is MNs, and occurs via the G-coupled octopamine receptor (OAMB).

View Article and Find Full Text PDF

Dissolution of CO in water followed by the subsequent hydrolysis reactions is of great importance to the global carbon cycle, and carbon capture and storage. Despite numerous previous studies, the reactions are still not fully understood at the atomistic scale. Here, we combined ab initio molecular dynamics (AIMD) simulations with Markov state models to elucidate the reaction mechanisms and kinetics of CO in supercritical water both in the bulk and nanoconfined states.

View Article and Find Full Text PDF

The diversity and heterogeneity of biomarkers has made the development of general methods for single-step quantification of analytes difficult. For individual biomarkers, electrochemical methods that detect a conformational change in an affinity binder upon analyte binding have shown promise. However, because the conformational change must operate within a nanometer-scale working distance, an entirely new sensor, with a unique conformational change, must be developed for each analyte.

View Article and Find Full Text PDF

Dysregulation of GABAergic inhibition is associated with pathological pain. Consequently, enhancement of GABAergic transmission represents a potential analgesic strategy. However, therapeutic potential of current GABA agonists and modulators is limited by unwanted side effects.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!